Hydreight Technologies to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025

Rhea-AI Summary

Hydreight Technologies (TSXV: NURS) (OTCQB: HYDTF) announced its upcoming presentation at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025. CEO Shane Madden will present at 12:30 PM PST and host a Q&A session.

The company is building one of the largest mobile clinical networks in the US, offering services like weight loss treatments, hormone therapy, IV wellness, and at-home testing. Recent achievements include:

• Launch of Liraglutide and sublingual semaglutide on VSDHOne platform
• US partnership with 'Dr. Frank's Method' GLP-1 weight-loss brand serving 70,000+ clients
• Launch of $10M health accelerator fund for emerging healthcare brands
• Ranked #13 on Financial Times' Americas' Fastest Growing Companies 2025
• #56 on Deloitte's Technology Fast 500™
• Top 50 on TSX Venture 50

Positive

• Ranked #13 on FT's Americas' Fastest Growing Companies 2025
• Expansion into GLP-1 market with new product launches
• Partnership with established brand serving 70,000+ clients
• $10M fund launched for healthcare brand investments
• Multiple prestigious rankings indicating strong growth

Negative

• None.

VANCOUVER, British Columbia and LAS VEGAS, April 17, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth services in the U.S., today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 12:30 PM (Local Time -PST). Shane Madden (CEO of Hydreight Technologies) will be hosting the presentation and answering questions at the conclusion.

To access the live presentation, please use the following information:

Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub
Date: Wednesday, April 23, 2025
Time: 12:30 PM (Las Vegas, NV Local Time PST)
Webcast Link: Hydreight Technologies (NURS.V)  

Why Attend Hydreight’s Presentation

Hydreight Technologies (TSXV: NURS | OTCQB: HYDTF) is building one of the largest mobile clinical networks in the United States. Our innovative platform allows healthcare professionals to deliver medical services—like weight loss treatments, hormone therapy, IV wellness, and at-home testing—directly to patients, wherever they are.

Hydreight’s model is built for where healthcare is going: on-demand, compliant, and consumer-first. We help clinics and D2C health brands launch fast—with full access to our national doctor network, pharmacy infrastructure, and a PC-friendly model that supports rapid, multi-state scaling.

Recent Highlights:

• GLP-1 Expansion: Recent launch of Liraglutide and sublingual semaglutide on our VSDHOne platform.
  
• Global Partnership: U.S. launch of “Dr. Frank’s Method,” a clinically proven GLP-1 weight-loss brand, with over 70,000 clients served.
• Health Accelerator: $10M fund launched to invest in emerging healthcare brands and onboard them to our ecosystem.
  
• Recognition: Ranked #13 on the Financial Times’ list of The Americas’ Fastest Growing Companies 2025, #56 on Deloitte’s Technology Fast 500™ and Top 50 on the TSX Venture 50

With the global weight loss market expected to surpass $400B by 2030 (Facts & Factors), and GLP-1 medications fueling unprecedented demand, Hydreight is positioned as a first mover in the telehealth and mobile wellness space.

Book 1x1 investor meetings with Hydreight Technologies

If you would like to book 1x1 investor meetings with Hydreight Technologies, and to attend the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, please make sure you are registered here: REGISTER

1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV.

If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: AGENDA

On behalf of the Board of Directors

Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.

Hydreight Technologies Inc Ranked Number 56 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Hydreight Technologies Recognized as a Top 50 TSX Venture Exchange Company

Hydreight Technologies Recognized by the Financial Times Ranking 13th as One of the Americas’ Fastest Growing Companies in 2025

Contact
Email: ir@hydreight.com; Telephone: 1 (702) 970-8112

About Planet MicroCap

Planet MicroCap is a global multimedia financial news, publishing and events company for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.

About Hydreight Technologies Inc.

Hydreight Technologies Inc is building one of the largest mobile clinic network in the United States. Its proprietary, fully integrated platform hosts a network of over 3000 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

About VSDHOne - Direct to Consumer Platform

Developed in partnership with Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6), Hydreight Technologies launched the VSDHOne (Read as VSDH-One) platform. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the online healthcare space compliantly. This platform will help all businesses to launch a direct-to-consumer healthcare brand in a matter of days in all 50 states. Compliant offerings include: GLP-1s (semaglutide, tirzepatide, liraglutide), peptides, personalized healthcare treatments, sermorelin, testosterone replacement therapy (“TRT”), hair loss, skincare, sexual health and more. Hydreight invested in technology, legal and infrastructure to launch this platform. The VSDHOne platform offers a complete, end-to-end solution for businesses looking to launch direct-to-consumer healthcare brands. From compliance and telemedicine technology to nationwide doctor and pharmacy networks, VSDHOne provides all the tools needed for a seamless entry into the online healthcare space. The platform is designed to significantly reduce the time and costs associated with launching such services, making it possible for businesses to go live in days instead of months.

Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, path to profitability, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “projecting”, “expect” or similar expressions and includes information regarding expectations for the Company's growth, Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company’s shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions. All numbers, information and data about "Dr. Franklin Joseph", and his company and achievements have been provided by Dr. Franklin Joseph and his team and Hydreight doesn't accept responsibility for the adequacy or accuracy of those.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

FAQ

What services does Hydreight Technologies (HYDTF) offer through its mobile clinical network?

Hydreight offers weight loss treatments, hormone therapy, IV wellness, and at-home testing services through its mobile clinical network, delivering medical services directly to patients.

What are the recent GLP-1 developments for Hydreight stock (HYDTF)?

Hydreight recently launched Liraglutide and sublingual semaglutide on their VSDHOne platform and partnered with 'Dr. Frank's Method' for GLP-1 weight-loss services.

How has Hydreight Technologies (HYDTF) performed in industry rankings for 2025?

Hydreight ranked #13 on Financial Times' Americas' Fastest Growing Companies 2025, #56 on Deloitte's Technology Fast 500™, and made the Top 50 TSX Venture 50.

What is Hydreight's (HYDTF) new investment initiative in healthcare?

Hydreight launched a $10M health accelerator fund to invest in emerging healthcare brands and integrate them into their ecosystem.